NAVIGANT ANALYSIS STEERS MEDTECH MULTINATIONAL’S DECISION ON ACQUISITION INVESTMENT WORTH HUNDREDS OF MILLIONS CHALLENGE With high hopes, a multinational medical device company leadership team came to Navigant Consulting, Inc. to examine the value of a potential acquisition. The opportunity appeared to be the long-awaited key to unlock a sizable market for a minimally invasive therapy to prevent a common condition. The product in question was an adjunctive device for a minimally invasive vascular procedure. Unlike other similar solutions that had come to market and stalled, this one seemed to address the major barriers that historically had prevented widespread adoption of this procedure. Specifically, it showed the best clinical outcomes to date, had obtained incremental reim

Join for free to read